FDA
approval
· 2023-12-09
FDA Approved: PALYNZIQ — Supplemental Application (BioMarin Pharmaceutical Inc.)
Summary
The FDA approved BioMarin's supplemental Biologics License Application for PALYNZIQ (pegvaliase-pqpz). The approval covers an additional submission for the drug…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PALYNZIQ (PEGVALIASE-PQPZ)